MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$2,932K
EPS
-$4
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
General and administrative
1,916 1,212* 1,814 1,279
Research and development
773 704* 1,275 1,871
Total operating expenses
2,689 1,916 3,089 3,150
Loss from operations
-2,689 -1,916* -3,089 -3,150
Gain on investment
-6* --
Interest income
1 -5 1
Interest expense
100 -80* 111 72
Interest expense - related party
-21* --
Loss on extinguishment of debt
--206* --
Loss on extinguishment of debt - related party
-83* --
Interest expense - related party
24 ---
Net change in fair value of derivative liability
-146 -1,098* 75 -
Net change in fair value of trading marketable securities
-0* 0 0
Total other income (expense)
-269 -1,322* -31 -71
Provision for income taxes
-0* 0 0
Net loss
-2,958 -3,238* -3,120 -3,221
Foreign currency translation adjustments
26 -124 18 -68
Total other comprehensive income (loss)
26 -124* 18 -
Total comprehensive loss
-2,932 -3,362 -3,102 -3,289
Diluted EPS
-4 -1.948 -3.97 -5.61
Diluted Average Shares
739,000 1,726,000 787,000 574,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Foreign currencytranslation adjustments$26K Total comprehensiveloss-$2,932K Total othercomprehensive income (loss)$26K Net loss-$2,958K Loss from operations-$2,689K Total other income(expense)-$269K Interest income$1K Total operatingexpenses$2,689K Net change in fairvalue of derivative...-$146K Interest expense$100K Interest expense -related party$24K General andadministrative$1,916K Research and development$773K

ARTELO BIOSCIENCES, INC. (ARTL)

ARTELO BIOSCIENCES, INC. (ARTL)